Korean J Gastroenterol.  2023 Apr;81(4):181-184. 10.4166/kjg.2023.033.

Effect of Screening Colonoscopy on Reduction of Risk Colorectal Cancer and Related Mortality

• Kim MC

• KMID: 2541782
• DOI: http://doi.org/10.4166/kjg.2023.033

Reference

1. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021; 71:209–249. DOI: 10.3322/caac.21660. PMID: 33538338.

2. Bibbins-Domingo K, Grossman DC, Curry SJ, et al. 2016; Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA. 315:2564–2575. Erratum in: JAMA 2017;317:2239. DOI: 10.1001/jama.2016.5989. PMID: 27304597.

3. Basu P, Ponti A, Anttila A, et al. 2018; Status of implementation and organization of cancer screening in The European Union Member States-Summary results from the second European screening report. Int J Cancer. 142:44–56. Erratum in: Int J Cancer 2018;143:E1. DOI: 10.1002/ijc.31043. PMID: 28940326.

4. Bretthauer M, Løberg M, Wieszczy P, et al. 2022; Effect of colonoscopy screening on risks of colorectal cancer and related death. N Engl J Med. 387:1547–1556. DOI: 10.1056/NEJMoa2208375. PMID: 36214590.

5. Ladabaum U, Dominitz JA, Kahi C, Schoen RE. 2020; Strategies for colorectal cancer screening. Gastroenterology. 158:418–432. DOI: 10.1053/j.gastro.2019.06.043. PMID: 31394083.

6. Lin JS, Perdue LA, Henrikson NB, Bean SI, Blasi PR. 2021; Screening for colorectal cancer: Updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 325:1978–1998. Erratum in: JAMA 2021;326:279. DOI: 10.1001/jama.2021.4417. PMID: 34003220.

7. Brenner H, Stock C, Hoffmeister M. 2014; Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies. BMJ. 348:g2467. DOI: 10.1136/bmj.g2467. PMID: 24922745. PMCID: PMC3980789.

8. Zauber AG, Winawer SJ, O'Brien MJ, et al. 2012; Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med. 366:687–696. DOI: 10.1056/NEJMoa1100370. PMID: 22356322. PMCID: PMC3322371.

9. Schottinger JE, Jensen CD, Ghai NR, et al. 2022; Association of physician adenoma detection rates with postcolonoscopy colorectal cancer. JAMA. 327:2114–2122. DOI: 10.1001/jama.2022.6644. PMID: 35670788. PMCID: PMC9175074.

10. Bretthauer M, Kaminski MF, Løberg M, et al. 2016; Population-based colonoscopy screening for colorectal cancer: A randomized clinical trial. JAMA Intern Med. 176:894–902. DOI: 10.1001/jamainternmed.2016.0960. PMID: 27214731. PMCID: PMC5333856.

11. Forsberg A, Westerberg M, Metcalfe C, et al. 2022; Once-only colonoscopy or two rounds of faecal immunochemical testing 2 years apart for colorectal cancer screening (SCREESCO): preliminary report of a randomised controlled trial. Lancet Gastroenterol Hepatol. 7:513–521. Erratum in: Lancet Gastroenterol Hepatol 2022;7:508. DOI: 10.1016/S2468-1253(21)00473-8. PMID: 35298893.

12. Quintero E, Castells A, Bujanda L, et al. 2012; Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med. 366:697–706. Erratum in: N Engl J Med 2016;374: 1898. DOI: 10.1056/NEJMx150040.

13. Dominitz JA, Robertson DJ, Ahnen DJ, et al. 2017; Colonoscopy vs. fecal immunochemical test in reducing mortality from colorectal cancer (CONFIRM): Rationale for study design. Am J Gastroenterol. 112:1736–1746. DOI: 10.1038/ajg.2017.286. PMID: 29016565.